Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Chest Wall Tumor
Interventions: DRUG: Pembrolizumab
Sponsor: European Institute of Oncology